853
Participants
Start Date
March 8, 2011
Primary Completion Date
September 18, 2013
Study Completion Date
September 18, 2013
Advagraf
oral
Mycophenolate Mofetil
oral
Sirolimus
oral
Corticosteroids
i.v. and oral
1940, Budapest
1140, Vienna
1241, Leuven
1240, Liège
1142, Linz
1141, Innsbruck
1750, Dijon
1547, Kiel
1740, Brest
1540, Hanover
1751, Toulouse
5342, Taoyuan District
3043, Istanbul
1545, Hannoversch Münden
3044, Istanbul
1748, Tours
1643, Santander
1541, Bochum
1543, Essen
1550, Münster
1642, Vizcaya
2140, Siena
1745, Vandœuvre-lès-Nancy
1544, Frankfurt
1742, Clermont-Ferrand
1546, Heidelberg
5343, Tainan City
1749, Paris
1752, Amiens
1549, München
2144, Palermo
1542, Erlangen
1746, Créteil
1741, Le Kremilin Bicetre Cedex
2843, Moscow
3240, Minsk
2840, Vol'ginskiy
2842, Omsk
2841, Kemerovo
5042, New Lambton
5043, Perth
Site 1441, Brno
1440, Ostrava - Poruba
1548, Leipzig
5441, Hong Kong
2143, Roma
2440, Maastricht
2643, Katowice
2640, Lodz
2641, Poznan
5245, Busan
5243, Daegu
5242, Seoul
5241, Seoul
5244, Seoul
1640, Alicante
1641, Barcelona
3042, Istanbul
Lead Sponsor
Astellas Pharma Inc
INDUSTRY